NEW: 🇺🇸 Senator Lummis has introduced new digital asset legislation that "secures key victories for the digital asset industry and creates a level playing field for digital asset users across the country." https://t.co/MwMPHJMQdu ...

Key Takeaways HIMS is advancing an AI-powered healthcare platform to boost personalization and accessibility. Mo Elshenawy was appointed as CTO in May to lead AI integration across diagnosis, treatment and delivery. HIMS raised $870 million in convertible notes, partly to fund AI tools and personalized treatment expansion.The renowned health and wellness platform, Hims & Hers Health, Inc. (HIMS) , is actively leveraging artificial intelligence (AI) to revolutionize the delivery of healthcare, aiming to ma ...

Core Viewpoint - Criteo S.A. (CRTO) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system emphasizes the importance of earnings estimate revisions, which have shown a strong correlation with near-term stock price movements [4][6]. - For the fiscal year ending December 2025, Criteo is expected to earn $4.39 per share, with a 12% increase in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Criteo's upgrade to Zacks Rank 1 places it in the top 5% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10].

Key Takeaways TBLA stock has jumped 36.5% in 3 months, outperforming its industry, sector and the market. TBLA is expanding into display and commerce formats via its Realize platform to tap a $55B market. Revenues were $1.8B in 2024 and are expected to be $1.89B in 2025, with growing profit and strong cash flow.Shares of Taboola.com Ltd. (TBLA) have rallied 36.5% in the past three months, zooming past its industry, sector and the Zacks S&P 500 composite in the same time frame.TBLA is now trending above i ...

Villers-lès-Nancy (France), July 03, 2025 – 06 :00pm (CET) Press Release Equasens announces the departure of Damien VALICON, as Deputy Chief Executive Officer and Director of the Pharmagest Division He will be replaced by François-Pierre MARQUIER as Director of the Pharmagest Division. *** Equasens Group (Euronext Paris™ - Compartment B - FR 0012882389 –$EQS), announces the departure of Damien VALICON, who held the position of Deputy Chief Executive Officer and Director of the Pharmagest Division for 18 mo ...

Core Insights - OptimizeRx (OPRX) has reported strong first-quarter results for fiscal 2025, exceeding Wall Street expectations and reflecting positively in its share price performance over the past three months [1][4]. Financial Performance - Revenue increased by 11% year over year to $21.9 million, with a positive operating cash flow of $3.9 million, marking a significant turnaround from the previous year [2][10]. - Contracted revenues grew by 25% year over year, now exceeding $70 million, which accounts for over 80% of the midpoint of the FY25 revenue guidance [9][11]. - Gross margins remained steady at 60.9%, while operating expenses declined due to reduced stock-based compensation and cost controls [7][10]. Market Position and Growth - OPRX's shares surged by 69.3% in the past three months, significantly outperforming the broader industry growth of 36.7% and the S&P 500's gain of 22.1% during the same period [4][5]. - The company is transitioning to a subscription-based revenue model, with over 5% of projected 2025 revenues already tied to recurring contracts, particularly in its DAAP and Medicx data businesses [12][10]. Valuation - OPRX is attractively priced, trading at a forward price-to-sales (P/S) ratio of 2.2X, well below its five-year median of 3.64X and the industry average of 8.64X [13]. Strategic Outlook - Management has raised its full-year guidance and reaffirmed its ambition to achieve Rule of 40 metrics, indicating a combined annual revenue growth rate and EBITDA margin of 40% or higher within the next several years [2][10]. - The company is focused on deepening client relationships and scaling its omnichannel platform, which is expected to create sustained shareholder value in the evolving healthcare ecosystem [3].

Group 1 - Shares of PubMatic, Inc. have rebounded approximately 70% from their all-time low of $7.46 set on April 7, 2025, which marked a 90% decline from their all-time high [1] - The digital advertising landscape is evolving, potentially favoring supply-side platforms like PubMatic [1] - The Busted IPO Forum, led by Bret Jensen, focuses on stocks that have been public for 18 months to 6 years and are significantly under their offering price [1]

Hong Kong, July 03, 2025 (GLOBE NEWSWIRE) -- VS MEDIA Holdings Limited (Nasdaq: VSME), a leading digital media and social commerce company in the global Creator Economy, today announced that it received formal notification from the Nasdaq Stock Market LLC (“Nasdaq”) on July 2, 2025, that the Company has regained compliance with Nasdaq Listing Rule 5550(b). This rule requires the Company to meet at least one of the following standards: (1) stockholders’ equity of at least $2.5 million; (2) market value of li ...

21世纪经济报道记者 黄子潇 深圳报道 上市未满一月， "稳定币第一股" Circle重手申请银行牌照。 当地时间6月30日，USDC稳定币的发行商Circle官宣，已正式向美国货币监理署（OCC）提交申请，拟 设立一家国家信托银行——第一国家数字货币银行（First National Digital Currency Bank, N.A.）。 根据Circle官网介绍，该银行将作为受OCC监管的托管机构运营，获批后，Circle将借此自主托管超过 600亿美元的储备资金，亦能为机构客户提供数字资产托管服务。 尽管发行USDT（泰达币）的Tether仍是最大的稳定币发行商，Circle位居第二，但Circle在宣传USDC时 增加一个"全球最大受监管支付稳定币"的定语，以押注合规性的红利。在上个月登陆纽交所后，Circle 成为"稳定币第一股"。 对于Circle而言，2023年硅谷银行危机导致USDC脱锚至0.87美元的教训仍历历在目。 业内人士向21世纪经济报道记者表示，Circle 设立银行有助于提升储备资金的安全性和透明度，并降低 第三方托管成本，Circle正在从单一的稳定币发行人转型为合规的金融基 ...

Key Takeaways HBM, STRL, MOH and VRT boast strong interest coverage ratios, signaling solid financial footing. HBM and STRL posted more than 40% EPS growth estimates, while VRT shows 24.9% growth potential. MOH projects 8.4% sales growth and 7.9% EPS growth, despite a 19.3% stock decline over the past year.Markets ended higher on Wednesday as investors weighed the latest developments in trade and the economy. Both the S&P 500 and Nasdaq Composite indices closed higher, advancing 0.47% and 0.94%, respectiv ...